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Probiotics in human gut 
microbiota can degrade host 
glycosaminoglycans
Keigo Kawai1, Reiko Kamochi2, Sayoko Oiki1, Kousaku Murata3 & Wataru Hashimoto1,2
Glycosaminoglycans (GAGs) (e.g. heparin, chondroitin sulfate, and hyaluronan) show various significant 
physiological functions as a major component of extracellular matrix in animals. Some bacteria target 
GAGs for adhesion and/or infection to host cells, although no probiotics have been known to degrade 
GAGs. Here, we show GAG degradation by probiotics from human gut microbiota and their adhesion to 
human intestinal cells through a GAG. GAG-degrading bacteria were isolated from human faeces and 
identified as Enterococcus faecium, and some typical probiotics such as Lactobacillus casei, Lactobacillus 
rhamnosus and Enterococcus faecalis were also found to degrade heparin. GAG-degrading lactobacilli 
and enterococci including the isolated E. faecium possessed a genetic cluster encoding GAG-degrading/
metabolising enzymes in the bacterial genome. KduI and KduD enzymes encoded in the GAG cluster 
of L. rhamnosus functioned as 4-deoxy-l-threo-5-hexosulose-uronate ketol-isomerase and 2-keto-
3-deoxy-d-gluconate dehydrogenase, respectively, both of which were crucial for GAG metabolism. 
GAG-degrading L. rhamnosus and E. faecium attached to human intestinal Caco-2 cells via heparin. 
Some species of Bacteroides, considered to be the next generation probiotics, degraded chondroitin 
sulfate C and hyaluronan, and genes coding for the Bacteroides GAG-degrading enzyme were frequently 
detected from human gut microbiota. This is the first report on GAG-degrading probiotics in human gut 
microbiota.
Animal cells are enveloped with an extracellular matrix constituted by a complex of supramolecules such as 
structural proteins, polysaccharides, and proteoglycans1. Glycosaminoglycans (GAGs), the major components of 
the extracellular matrix, are heteropolysaccharides constituted by the repetitive disaccharide units of uronic acid 
(or galactose) and amino sugar residues2. Based on their sugar composition, linkage mode of the sugar residues, 
and sulfation level, GAGs ubiquitously present in all mammalian tissues are classified mainly as hyaluronan, 
chondroitin sulfate, dermatan sulfate, heparan sulfate, heparin, or keratan sulfate (Fig. S1). Except for hyaluronan, 
these GAGs are covalently bound to core proteins, resulting in the formation of proteoglycans.
A large number of bacteria such as Streptococcus, Listeria, Helicobacter, Enterococcus and Lactobacillus tar-
get mammalian GAGs for colonisation and/or infection to host cells3,4. Among these, a few bacteria includ-
ing Streptococcus are known to degrade GAGs5,6, although GAG binding by GAG-degrading bacteria such as 
Bacteroides and Clostridium7 remains to be clarified. In the case of Streptococcus, hyaluronan is depolymerised 
to an unsaturated disaccharide with a double bond in C4–C5 at the non-reducing terminus by cell-surface hya-
luronate lyase (HysA) through a β-elimination reaction5. Our previous reports demonstrated that the resultant 
unsaturated disaccharide was degraded into two constituent monosaccharides (unsaturated glucuronic acid and 
N-acetyl-d-glucosamine) by cytoplasmic unsaturated glucuronyl hydrolase (UGL)8, and that 4-deoxy-l-threo-
5-hexosulose-uronic acid (α-keto acid, DHU) non-enzymatically converted from unsaturated glucuronic acid 
was metabolised to pyruvate and glyceraldehyde-3-phosphate by consecutive reactions of isomerase (DhuI), 
NADH-dependent reductase (DhuD), kinase (KdgK), and aldolase (KdgA)9. These enzymes (HysA, UGL, DhuI, 
DhuD, KdgK, and KdgA) for depolymerisation, degradation and metabolism of GAGs are coded in a GAG 
1Laboratory of Basic and Applied Molecular Biotechnology, Division of Food Science and Biotechnology, Graduate 
School of Agriculture, Kyoto University, Uji, Kyoto, 611-0011, Japan. 2Laboratory of Basic and Applied Molecular 
Biotechnology, Department of Food Science and Biotechnology, Faculty of Agriculture, Kyoto University, Uji, Kyoto, 
611-0011, Japan. 3Laboratory of Food Microbiology, Department of Life Science, Faculty of Science and Engineering, 
Setsunan University, Neyagawa, Osaka, 572-8508, Japan. Correspondence and requests for materials should be 
addressed to W.H. (email: whasimot@kais.kyoto-u.ac.jp)
Received: 19 September 2017
Accepted: 2 July 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SciEntiFic REPORtS |  (2018) 8:10674  | DOI:10.1038/s41598-018-28886-w
genetic cluster (Fig. 1A). The cluster also contains gene encoding components (enzymes IIA, B, C and D) of a 
putative phosphotransferase system (PTS) for the import of GAG disaccharide.
Similar GAG genetic clusters are found in the genome of various bacteria, most of which are pathogenic. 
Especially, the gene coding for UGL is universally included in GAG clusters, and the enzyme is unique in the deg-
radation of unsaturated GAG disaccharides to constituent monosaccharides. On the other hand, there is a variety 
in the genetic organisation (e.g. import system and metabolic enzymes) in the GAG clusters. In place of PTS, 
we have recently identified an ATP-binding cassette transporter encoded in the GAG cluster of Streptobacillus 
moniliformis as a first importer of unsaturated GAG disaccharides to the bacterial cells10 (Fig. 1B). Two genes for 
isomerase KduI and reductase KduD responsible for pectin metabolism11 are also included in the GAG cluster, 
and KduI and KduD seem to correspond to DhuI and DhuD, respectively9, although the action of KduI and KduD 
toward GAG-derived products remains unclear.
Figure 1. Varieties of bacterial GAG genetic clusters. (A) Streptococcus pneumoniae (strain R6). (B) S. 
moniliformis. (C) L. rhamnosus (strain Lc705). (D) L. casei subsp. casei. (E) E. faecium strain H57. Four or five 
digits indicate gene ID numbers of each bacterium (spr#### in S. pneumoniae, Smon_#### in S. moniliformis, 
Lc705_##### in L. rhamnosus and LSEI_#### in L. casei subsp. casei). Gene products are shown under gene 
ID. Isomerase and reductase similar to KduI and KduD for pectin metabolism, respectively, were encoded 
in the Strepobacillus, Lactobacillus and Enterococcus GAG clusters, while the Streptococcus cluster codes 
experimentally identified isomerase DhuI and reductase DhuD involved in GAG metabolism.
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To the best of our knowledge, no reports on the degradation of GAGs by Lactobacillus, a typical member of 
probiotics, have been published, although some strains of the genus are attached to host cells by GAG binding4. 
For GAG-targeting bacteria including probiotics, GAGs are attractive nutritionally because polysaccharides are 
constitutively produced on the cell surface by hosts. Thus, studies on the mechanism of degradation and metabo-
lism of GAGs by probiotics will contribute to the development of novel prebiotics for the enhanced colonisation 
of beneficial bacteria in the human gut. This article deals with the degradation and metabolism of GAGs by 
probiotics and adhesion of GAG-degrading probiotics to human intestine cells via GAG. The predominance of 
Bacteroides in human gut microbiota was also examined through a GAG degradation analysis and metagenomics 
regarding the UGL gene.
Results
GAG degradation by human gut microbiota. In this study, three GAGs, i.e. heparin, chondroitin sulfate 
C and hyaluronan were used as substrates for bacterial degradation (Fig. S1). GAG degradation was examined 
by a co-culture of human gut microbiota. Microbes included in the faeces of Japanese man in his 20’s were anaer-
obically co-cultured in a nutrition medium containing heparin or chondroitin sulfate C. The culture broth was 
periodically sampled and subjected to thin-layer chromatography (TLC) and a GAG colorimetric assay (Fig. 2). 
No GAG degradation was observed by Escherichia coli cells or in the saline used as a negative control. After 
co-culture for 6d, spots at the origin corresponding to both heparin and chondroitin sulfate C were found to 
be gradually diminished, and were completely degraded in the co-culture sample by day 9 (Fig. 2A). Similarly, 
GAG concentration in the culture broth decreased between days 7 and 9 (Fig. 2B). Degradation of heparin and 
chondroitin sulfate C by gut microbiota was also observed in the other Japanese man in his 50’s and woman in 
her 20’s (Fig. S2). Gut microbiota from these two Japanese formed a clear halo12 on the medium plate contain-
ing heparin or chondroitin sulfate C, revealing that GAG-degrading microbes were included in the human gut 
microbiota (Fig. 2C). The results obtained here demonstrated that GAGs were completely degraded by human 
gut microbiota.
GAG-degrading bacteria isolated from human gut microbiota. Two GAG-degrading bacteria 
termed strains H57 and H59 were isolated from human faeces by anaerobic enrichment cultivation using 
GAG-included plates. Degradation of GAGs (heparin, chondroitin sulfate C and hyaluronan) was further inves-
tigated by a plate assay for halo (clear zone) detection12 (Fig. 3). GAG-degrading Pedobacter heparinus used as 
a positive control formed halos on all the three plates containing the GAGs tested here, while no GAG degrada-
tion by E. coli used as a negative control was observed. Strain H57 and H59 cells were found to degrade heparin 
and hyaluronan, and a faint halo was observed on the chondroitin sulfate C plate with strain H57 cells. On the 
basis of the 16S rRNA sequence analysis, both strains H57 and H59 were identified as members of the probiotic 
Enterococcus faecium13, while this species is also known to be an opportunistic pathogen14.
Since strains H57 and H59 were a first example of enterococci degrading GAGs, strain H57 was subjected to 
the draft genome sequence analysis. The total coding length of the whole H57 genome was 2,583,114, and its reads 
were assembled into 108 contigs. Each contig was designed as NODE_1 to 173 in the GenBanK/EMBL/DDBJ 
databases (Table S1). The key enzyme UGL for GAG degradation was encoded in NODE_71, and putative genes 
coding for NagE (PTS, N-acetylglucosamine-specific EIICBA components) and metabolic enzymes (KduI, KduD, 
KdgK, and KdgA) of α-keto acid (DHU) were included in NODE_35 and 92, respectively (Fig. 1E).
Degradation and metabolism of GAGs by probiotics. Distinct from pathogens such as streptococci 
and clostridia, the probiotic strains H57 and H59 were found to degrade GAGs and some typical probiotics 
including Enterococcus, Lactobacillus, and Bifidobacterium (Table 1) were also subjected to the plate assay for 
GAG degradation (Fig. 3). Heparin was degraded by Enterococcus faecalis, Lactobacillus animalis, Lactobacillus 
casei, Lactobacillus casei subsp. casei, Lactobacillus casei subsp. rhamnosus, Lactobacillus pantheris, Lactobacillus 
paracasei subsp. paracasei and Lactobacillus rhamnosus. In addition to heparin, L. casei and L. pantheris seemed 
to slightly degrade chondroitin sulfate C. Degradation of any GAGs was hardly detected by the following probiot-
ics: Lactobacillus acidophilus, Lactobacillus aviarius subsp. aviarius, Lactobacillus brevis, Lactobacillus parabuch-
neri, Lactobacillus paracasei subsp. torelans, Lactobacillus reuteri, Lactobacillus saerimneri and Bifidobacterium 
bifidum.
Among GAG-degrading lactobacilli, some strains classified to L. casei, L. paracasei and L. rhamnosus were 
found to contain the GAG genetic cluster in the bacterial genome (Fig. 1C,D). The recombinant L. rhamnosus 
HepC annotated as heparinase II/III family protein encoded in the bacterial GAG genetic cluster seemed to 
degrade heparin through a β-elimination reaction (Iwase et al. Abstract paper presented at Regular Meeting of 
Kansai Branch of the Japan Society for Bioscience, Biotechnology, and Agrochemistry, held in Kyoto, Japan on 
February 3, 2018). Two genes coding for KduI and KduD were also included in the Lactobacillus cluster, although 
both are generally located in the genome segment of pectin-degrading bacteria11. KduI and KduD were first iden-
tified to be isomerase and reductase, respectively, for the metabolism of unsaturated galacturonic acid generated 
from pectin15,16. On the other hand, there is no experimental evidence for involvement of these KduI and KduD 
in metabolism of GAGs. Due to high sequence identity among Lactobacillus KduIs or KduDs, two recombinant 
KduI and KduD of L. rhamnosus were expressed as typical Lactobacillus proteins in E. coli cells and purified to 
homogeneity (Fig. 4A).
α-Keto acid DHU non-enzymatically produced from unsaturated uronic acids from GAGs is converted 
to 3-deoxy-d-glycero-2,5-hexodiulosonic acid (DK-II) by DhuI9. The resultant product is reduced to 2-keto-
3-deoxy-d-gluconic acid (KDG) by NADH-dependent DhuD. Similar to DhuI and DhuD, KduI and KduD 
were found to be crucial for the metabolism of DHU. A combination assay using isomerase (KduI or DhuI) and 
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reductase (KduD or DhuD) indicated that KduI and KduD function as 4-deoxy-l-threo-5-hexosulose-uronate 
ketol-isomerase and 2-keto-3-deoxy-d-gluconate dehydrogenase, respectively (Fig. 4B).
GAG-degrading probiotics attached to intestinal Caco-2 cells. Although some lactobacilli 
and enterococci have been reported to show an adherence to Caco-2 cells17,18, we investigated the ability of 
GAG-degrading probiotics to attach to intestinal cells. Five probiotic heparin-degrading E. faecium strain H57, 
L. animalis, L. casei, L. casei subsp. rhamnosus and L. rhamnosus were subjected to the competition binding 
Figure 2. Degradation profiles of GAGs by human gut microbiota. Gut microbiota from human faeces were 
co-cultured for 21d in the nutrition medium containing heparin (left) and chondroitin sulfate C (right). The 
supernatants derived from periodically sampled culture broth were subjected to TLC (A) and GAG assays  
(B). Due to polysaccharides, GAGs on the TLC plates remained at the origin, indicated by an arrow (A). Square, 
round and diamond-shaped symbols represent samples from the co-culture of gut microbiota, E. coli culture 
and saline, respectively, in GAG degradation profiles (B). E. coli cells or the saline used as a negative control 
exhibited no GAG-degrading ability. After co-culture for 6d, spots at the origin corresponding to both heparin 
and chondroitin sulfate C as polysaccharides were found to be gradually diminished, and were completely 
degraded in the co-culture sample by day 9. Degradation profile by TLC (A) coincided with that by GAG assay 
(B). Degradation of heparin and chondroitin sulfate C by gut microbiota from Japanese man in his 50’s (upper) 
and woman in her 20’s (lower) was also confirmed by plate assay for halo detection (C). After growth of gut 
microbiota on GAG-containing nutrition medium plate for 7d (left), acetic acid was added on the plate for halo 
formation (right). The remaining GAG and BSA formed a complex as white precipitates. These profiles are not 
an image cropped from different parts of the same TLC or agar plate, or from different TLC or agar plates.
www.nature.com/scientificreports/
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assay (Fig. 5). All the probiotics showed an ability to attach to intestinal cells, although various adherence levels 
were observed, depending on the bacterial species. The adhesion of E. faecium strain H57 and L. rhamnosus to 
Caco-2 cells was significantly decreased by the addition of heparin, while in the case of the other three probiotics, 
there was no significant difference in their adhesion to intestinal cells between bacterial cells in the presence and 
absence of heparin.
Figure 3. Degradation of GAGs by probiotics. Various bacterial cells, including probiotic Enterococcus, 
Lactobacillus, and Bifidobacterium species were grown at the centre of the GAG + YE0.1 + BSA plate containing 
heparin (left), chondroitin sulfate C (centre) or hyaluronan (right) and subjected to GAG staining with acetic 
acid. P. heparinus and E. coli cells were used as positive and negative controls for GAG degradation, respectively.
www.nature.com/scientificreports/
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Frequent detection of Bacteroides UGL gene in human gut microbiota. Distinct from lactoba-
cilli probiotics, which are a minor bacterial component in human gut microbiota, several kinds of Bacteroides 
species predominant in the microbiota have been reported to degrade GAGs19–23. Recently, some Bacteroides 
species have been considered to be next generation probiotics beneficial to human health24,25, although the genus 
has long been known to be an opportunistic pathogen. In order to investigate the involvement of Bacteroides 
GAG-degrading ability in their predominance in the microbiota, 11 Bacteroides species, including the known 
GAG-degrading Bacteroides intestinalis, Bacteroides ovatus, Bacteroides stercoris and Bacteroides thethaiotaomi-
cron were subjected to the plate assay for GAG degradation (Fig. 6). In addition to the above four species, two 
species, i.e. Bacteroides clarus and Bacteroides paurosaccharoliticus, were found to degrade chondroitin sulfate C 
and hyauronan, while heparin was inert as a substrate for degradation by any Bacteroides species. Therefore, six 
Bacteroides species tested here were demonstrated to have a capability to degrade GAGs.
Based on the genome sequence of nine Bacteroides species so far determined, the UGL gene crucial for 
GAG degradation is found to be included in all of the Bacteroides genome. Thus, detection of the Bacteroides 
UGL gene was attempted by polymerase chain reaction (PCR) amplification through a metagenomic anal-
ysis using two Japanese faeces samples. According to the nucleotide sequences of five Bacteroides UGL 
genes, two specific forward and reverse primers for the Bacteroides UGL gene were designed, as follows: 
5′-ATBGAYAAYATGATSAAVCTSGA-3′ and 5′-GCYTGHCCRCGWGMCCA-3′ (Table S2). A gene fragment 
with a size of about 230 bp was predicted to be amplified from the genome of Bacteroides species through PCR 
using these primers. Two DNA samples were extracted from faecal samples obtained from two men in their 20’s 
and 40’s. Real Time (RT)-PCR toward two DNA samples in addition to genomic DNA of Bacteroides vulgatus as 
a positive control indicated that 230 bp DNA fragments were amplified from every DNA sample (Fig. S3). Based 
on the nucleotide sequences of PCR products, both the amplified DNA fragments from the two DNA samples 
were identified to be a part of the Bacteroides UGL gene. In order to determine the frequency of the Bacteroides 




Bacteroides clarus JCM 16067 30 Anaerobic GAM
Bacteroides dorei JCM 13471 37 Anaerobic GAM
Bacteroides helcogenes JCM 6297 37 Anaerobic GAM
Bacteroides intestinalis JCM 13265 37 Anaerobic GAM
Bacteroides ovatus JCM 5824 37 Anaerobic GAM
Bacteroides paurosaccharoliticus JCM 15092 30 Anaerobic GAM
Bacteroides salanitronis JCM 13657 37 Anaerobic GAM
Bacteroides stercoris JCM 9496 37 Anaerobic GAM
Bacteroides thetaiotaomicron JCM 5827 37 Anaerobic GAM
Bacteroides uniformis JCM 5828 37 Anaerobic GAM
Bacteroides vulgatus NBRC 14291 37 Anaerobic GAM
Bifidobacterium bifidum NBRC 100015 37 Anaerobic MRS
Enterococcus faecalis NBRC 100480 37 Anaerobic MRS
Enterococcus faecium strain H57 37 Anaerobic MRS
Enterococcus faecium strain H59 37 Anaerobic MRS
Escherichia coli K-12 MG1655 30 Anaerobic LB
Lactobacillus acidophilus NBRC 13951 37 Anaerobic MRS
Lactobacillus animalis NBRC 15882 37 Anaerobic MRS
Lactobacillus aviarius subsp. aviarius NBRC 102162 37 Anaerobic MRS
Lactobacillus brevis NBRC 107147 30 Anaerobic MRS
Lactobacillus casei NBRC 15883 37 Anaerobic MRS
Lactobacillus casei subsp. casei ATCC 334 37 Anaerobic MRS
Lactobacillus casei subsp. rhamnosus ATCC 8530 37 Anaerobic MRS
Lactobacillus pantheris NBRC 106106 37 Anaerobic MRS
Lactobacillus parabuchneri NBRC 107865 30 Anaerobic MRS
Lactobacillus paracasei subsp. paracasei NBRC 15889 37 Anaerobic MRS
Lactobacillus paracasei subsp. tolerans NBRC 15906 37 Anaerobic MRS
Lactobacillus reuteri NBRC 15892 37 Anaerobic MRS
Lactobacillus rhamnosus NBRC 3425 37 Non-aerobic MRS
Lactobacillus saerimneri NBRC 107826 37 Anaerobic MRS
Pedobacter heparinus NBRC 12017 30 Non-aerobic 802a
Table 1. List of bacteria used in this study and their preculture condition. aThe medium 802 consists of 1% 
hipolypeptone, 0.2% yeast extract and 0.1% MgSO4·7H2O.
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from RT-PCR analysis. In the case of the man in his 40’s, copy numbers of the 16S rRNA and Bacteroides UGL 
genes per 1 g of faeces were 5.60 × 1010 and 7.40 × 108, respectively. Similarly, copy numbers of the 16S rRNA and 
Bacteroides UGL genes per 1 g of faeces from the man in his 20’s were 2.07 × 1011 and 6.09 × 109, respectively. In 
this RT-PCR analysis, PCR efficiency and the correlation coefficient of the 16S rRNA gene were determined to be 
0.95 and 0.999, respectively, and those of the Bacteroides UGL gene were 0.79 and 0.999, respectively.
Figure 4. KduI and KduD involved in GAG metabolism. (A) SDS-PAGE profile of purified DhuI, DhuD, KduI 
and KduD. Lane M, molecular weight markers; lane 1, DhuI; lane 2, DhuD; lane 3, KduI; and lane 4, KduD. 
This profile is not an image cropped from different parts of the same gel or from different gels. (B) NADH 
oxidation (decrease in absorbance at 340 nm) through a successive reaction of isomerase (DhuI or KduI) 
and reductase (DhuD or KduD) in the presence of the substrate (DHU). The substrate was prepared from 
unsaturated chondroitin disaccharide with a sulfate group at C6 position through the reaction of UGL. Blue, the 
combination of DhuI and DhuD; purple, the combination of DhuI and KduD; green, the combination of KduI 
and DhuD; and red, the combination of KduI and KduD.
Figure 5. Bacterial attachment to Caco-2 cells. Bacterial cells attached to human intestinal cells were measured 
in each well in the presence (closed bar) and absence (open bar) of heparin. Strain 1, L. rhamnosus; strain 2, L. 
casei subsp. rhamnosus; strain 3, L. casei; strain 4, L. animalis; and strain 5, E. faecium strain H57. The adhesion 
of L. rhamnosus and E. faecium strain H57 was significantly decreased in the presence of heparin. Significant 
difference was statistically determined by Student’s t-test (**p < 0.01; *p < 0.05). The results are presented 
as means ± SD. Experiments were conducted independently in triplicate and cfu in each experiment was 
determined by three measurements.
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Discussion
In the present study, we found GAG-degrading probiotics in human gut microbiota and identified their abil-
ity to show an adherence to intestinal cells through GAG for the first time. Retardant degradation of GAGs 
(heparin and chondroitin sulfate C) was observed by the co-culture of human gut microbiota in the nutrition 
medium (Figs 2 and S2), suggesting that other nutrition factors such as yeast extract and/or tryptone rather 
than GAGs are readily utilised, but after their consumption, GAGs were available for the microbiota and they 
were finally completely degraded. Therefore, human gut microbiota are considered to usually utilise food-derived 
nutrition factors, and subsequently GAGs produced by hosts also become targets for degradation by some genera 
in the microbiota. Unsaturated disaccharides have been reported to be accumulated as an end-product through 
reactions by degradation of chondroitin sulfates by gut microbiota in the human Chinese populations7. On the 
other hand, in the case of GAG degradation by Japanese gut microbiota, no depolymerisation products such as 
unsaturated GAG disaccharides were observed after prolonged reaction on the TLC plate (Fig. 2A and Fig. S2), 
suggesting that after depolymerisation of GAGs by polysaccharide lyases, the resultant disaccharides were finally 
incorporated to the cytoplasm of the lyase producers and/or other bacteria.
Although some enterococci have been demonstrated to show an adherence to intestinal cells through heparin 
and/or heparan sulfate26, probiotic E. faecium strains H57 and H59 were isolated as the first GAG-degrading 
enterococci from human gut microbiota. Interestingly, no homologous genes coding for GAG lyases such as 
heparin lyases I, II, and III27,28 were observed in the genome of E. faecium strain H57. In comparison with the pre-
dominant genus Bacteroides in human gut microbiota (Fig. 6), enterococci showed less ability to degrade GAGs 
(Fig. 3), suggesting that enterococci utilise unsaturated GAG disaccharides produced by other bacteria. In fact, 
homologous proteins and enzymes essential for the import, degradation and metabolism of unsaturated GAG 
disaccharides are encoded in the genome of strain H57 (Fig. 1E).
Figure 6. Degradation of GAGs by Bacteroides species. Bacterial cells were grown at the centre of the 
GAG + YE0.1 + BSA plate containing heparin (left), chondroitin sulfate C (centre), or hyaluronan (right) and 
subjected to GAG staining with acetic acid.
www.nature.com/scientificreports/
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Molecular systems of depolymerisation, import, degradation and metabolism of GAGs have functionally and 
structurally been characterised in some pathogenic bacteria5,6,8–10 (Fig. 7, left). Genes coding for enzymes and 
proteins constituting the molecular systems are assembled to a cluster in some bacteria such as Streptococcus, 
Clostridium and Streptobacillus (Fig. 1). Other than such pathogenic bacteria, some probiotic lactobacilli are 
found to contain a similar GAG genetic cluster in their genomes. In fact, among GAG-degrading Lactobacillus 
species, i.e. L. animalis, L. casei, L. pantheris, L. paracasei and L. rhamnosus shown here, L. casei, L. paracasei and 
L. rhamnosus included the GAG genetic cluster, although no genome sequence of L. animalis and L. pantheris is 
available on the KEGG database (http://www.genome.jp/kegg/catalog/org_list.html).
As shown in Fig. 1C,D, the GAG cluster of Lactobacillus encodes KduI and KduD in place of streptococ-
cal isomerase DhuI and reductase DhuD. Due to a lack of the hydroxyl group at C4 position, unsaturated 
glucuronic and iduronic acids generated from GAGs are identical to unsaturated galacturonic acid9, suggest-
ing that the Lactobacillus KduI and KduD correspond to streptococcal GAG-metabolising DhuI and DhuD, 
respectively, although there is little sequence similarity between KduI and DhuI and between KduD and DhuD. 
Enzyme characterisation of the recombinant Lactobacillus KduI and KduD indicated that 4-deoxy-l-threo-
5-hexosulose-uronate ketol-isomerase KduI catalyses the isomerase reaction from DHU to DK-II, which is fur-
ther reduced to KDG by NADH-dependent reductase KduD. This is the first report to identify that KduI and 
KduD are crucial for GAG metabolism, and that these two metabolic enzymes together with KdgK and KdgA 
are also encoded in the genome of E. faecium strain H57 isolated as GAG-degrading bacterium from human gut 
microbiota (Fig. 1E). Therefore, based on the streptococcal system of action toward hyaluronan, the correspond-
ing Lactobacillus model for heparin degradation was postulated in Fig. 7, right. Heparin is depolymerised to 
unsaturated disaccharides by heparin lyase HepC categorised to polysaccharide lyase family 12 on the basis of the 
primary structure. The resultant unsaturated heparin disaccharide is incorporated into cytoplasm through phos-
phorylation by PTS composed of EII subunits A, B, C and D. The cytoplasmic enzyme UGL degraded the unsatu-
rated heparin disaccharide to unsaturated uronic acid and amino sugar. The resultant unsaturated uronic acid is 
Figure 7. Bacterial system for the degradation and metabolism of GAGs. Streptococcus and Lactobacillus 
systems for the degradation and metabolism of GAGs. GAGs such as hyaluronan (left) and heparin (right) were 
depolymerised to unsaturated disaccharides by cell-surface or extracellular polysaccharide lyases (PL8 family 
hyaluronate lyase HysA and PL12 family heparin lyase HepC). The resultant disaccharides were imported to the 
cytoplasm by putative PTS and degraded to constituent monosaccharides (unsaturated uronic acid and amino 
sugar) by cytoplasmic UGL before or after desulfation by sulfatase. DHU non-enzymatically produced from 
unsaturated uronic acid was converted to KDG via an intermediate DK-II through a sequential reaction by 
isomerase (DhuI or KduI) and NADH-dependent reductase (DhuD or KduD).
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non-enzymatically converted to DHU, which is further metabolised to pyruvate and glyceraldehyde-3-phosphate 
through successive reactions of isomerase KduI, NADH-dependent reductase KduD, kinase KdgK and aldolase 
KdgA.
The attachment of two heparin-degrading probiotics L. rhamnosus and E. faecium strain H57 to Caco-2 cells 
was significantly inhibited by heparin (Fig. 5), indicating that the two bacterial cells showed an adherence to the 
host intestinal cells through heparin, although other strains of these bacteria have been demonstrated to attach 
to the host cells3,4. On the other hand, little effect of heparin on the attachment of heparin-degrading L. animalis, 
L. casei and L. casei subsp. rhamnosus cells to the intestinal cells was observed, suggesting that these lactobacilli 
showed less ability to bind to the extracellular matrix heparin of Caco-2 cells. Therefore, further experiments are 
required to clarify the involvement of the bacterial GAG-degrading ability in the attachment to host cells. At least, 
GAG-degrading bacteria are beneficial for their residence and/or colonisation in host tissues because GAGs are 
constitutively produced on the cell surface by hosts.
Although several Bacteroides species in intestinal microflora are known to degrade GAGs19–23, two species, 
i.e. B. clarus and B. paurosaccharolyticus, were freshly demonstrated to degrade chondroitin sulfate C and hyalu-
ronan (Fig. 6). Six Bacteroides species tested here degraded GAGs, suggesting that degradation of GAGs is well 
conserved in Bacteroides species. This was supported by metagenomics through amplification of the Bacteroides 
UGL gene, which is crucial for the degradation of unsaturated GAG disaccharides. Copy numbers of 16S rRNA 
genes are generally known to be 1 to 15 in the genome of bacterial cells29. If copy numbers of 16S rRNA and 
Bacteroides UGL genes in each bacterial cell were estimated to be 8 and 1, respectively, the ratio of bacteria having 
the Bacteroides UGL gene in total gut microbiota was determined to be 23.5% and 10.5% in the men in their 20’s 
and 40’s, respectively. A potent GAG degradation ability and frequent detection of the Bacteroides UGL gene in 
human gut microbiota may contribute to the predominance of Bacteroides species in the microbiota due to attrac-
tive nutrients (GAGs) from hosts.
In conclusion, some typical and next generation probiotics including Lactobacillus, Enterococcus and 
Bacteroides in human gut microbiota, can degrade GAGs. Genes coding for the GAGs-degrading enzyme were 
frequently detected from human gut microbiota, suggesting that the bacterial GAG-degrading ability may be 
involved in their predominance in gut microbiota.
Materials and Methods
Materials. Sodium heparin (heparin) was purchased from Nacalai Tesque. Chondroitin sulfate C sodium 
salt (chondroitin sulfate C) was purchased from Wako Pure Chemical Industries. Hyaluronic acid sodium salt 
(hyaluronan) was purchased from Sigma-Aldrich. Generally, heparin consists of uronic (glucuronic or idu-
ronic) acid and glucosamine, both of which are linked by the 1,4-glycoside bond and are frequently sulfated and 
N-acetylated. Chondroitin sulfate C has a repeating disaccharide with the 1,3-glycosidic bond that is composed 
of glucuronic acid and N-acetyl-d-galactosamine with a sulfate group at the C6 position. Hyaluronan with no 
sulfate group is composed of glucuronic acid and N-acetyl-d-glucosamine, and shows a similar glycoside bond 
mode to chondroitin sulfate C. Nutrition-rich media, MRS and GAM, were purchased from BD Biosciences 
and the Nissui Pharmaceutical Co., respectively. Oligonucleotides were synthesised by Hokkaido System Science 
(Table S2). DNA-modifying enzymes were purchased from Toyobo. All other analytical grade chemicals used in 
this study were commercially available. Faeces were kind gifts from three Japanese volunteers in their 20’s, 40’s 
and 50’s. Informed consent was obtained from all subjects.
Bacterial strains and growth conditions. A list of bacteria used in this work is represented in Table 1. 
B. vulgatus NBRC 14291, B. bifidum NBRC 100015, E. faecalis NBRC 100480, L. acidophilus NBRC 13951, L. 
animalis NBRC 15882, L. aviarius subsp. aviarius NBRC 102162, L. brevis NBRC 107147, L. casei NBRC 15883, L. 
pantheris NBRC 106106, L. parabuchneri NBRC 107865, L. paracasei subsp. paracasei NBRC 15889, L. paracasei 
subsp. tolerans NBRC 15906, L. reuteri NBRC 15892, L. rhamnosus NBRC 3425, L. saerimneri NBRC 107826 and 
P. heparinus NBRC 12017 were purchased from the National Institute of Technology and Evaluation, Japan. L. 
casei subsp. casei ATCC 334 and L. casei subsp. rhamnosus ATCC 8530 were from the American Type Culture 
Collection. B. clarus JCM 16067, B. dorei JCM 13471, B. helcogenes JCM 6297, B. intestinalis JCM 13265, B. ovatus 
JCM 5824, B. paurosaccharoliticus JCM 15092, B. salanitronis JCM 13657, B. stercoris JCM 9496, B. thetaiotaomi-
cron JCM 5827 and B. uniformis JCM 5828 were from the Japan Collection of Microorganisms. Unless otherwise 
stated, the standard condition for bacterial growth in nutrition media is also described in Table 1.
Co-culture of human gut microbiota. A medium for the co-culture of human gut microbiota [0.4% (w/v) 
GAG (heparin or chondroitin sulfate C), 0.45% yeast extract, 0.3% tryptone, 0.3% peptone, 0.08% l-cysteine 
hydrochloride, 0.45% NaCl, 0.25% KCl, 0.045% MgCl2·6H2O, 0.02% CaCl2·2H2O and 0.04% KH2PO4] was pre-
pared according to the previous report with a slight modification30. A small portion of human faeces was resus-
pended in 1.5 ml saline (0.15 M NaCl) and 10 µl of the faecal suspension was added to 10 ml of the co-culture 
medium. Gut microbiota from faeces of two men in their 20’s and 50’s and a woman in her 20’s were anaerobically 
cultivated at 37 °C. In place of the faecal suspension, saline or a cell suspension of E. coli used as a negative control 
was also anaerobically incubated at 37 °C. A portion of the culture broth was periodically extracted for determi-
nation of GAG concentration. After centrifugation at 9,700 × g for 5 min at room temperature, the supernatant 
was stored at −20 °C until ready for use.
Isolation of GAG-degrading bacteria from human gut microbiota. To isolate GAG-degrading bac-
teria from human gut microbiota, three kinds of media were used, as follows: (i) GAG minimal plate [0.2% GAG 
(heparin or chondroitin sulfate C) as a sole carbon and nitrogen source, 0.1% Na2HPO4, 0.1% KH2PO4, 0.01% 
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MgSO4·7H2O and 1.5% agar], (ii) GAG + YE0.1 plate [0.2% GAG (heparin or chondroitin sulfate C), 0.1% yeast 
extract, 0.1% Na2HPO4, 0.1% KH2PO4, 0.01% MgSO4·7H2O and 1.5% agar], and (iii) GAG + YE0.5 plate [0.2% 
GAG (heparin or chondroitin sulfate C), 0.5% yeast extract, 0.1% Na2HPO4, 0.1% KH2PO4, 0.01% MgSO4·7H2O 
and 1.5% agar]. For maintenance and/or preculture, the bacterial cells were grown in nutrition-rich media such as 
LB plate (1% tryptone, 0.5% yeast extract, 1% NaCl and 1.5% agar) and/or MRS plate. The above-described human 
gut microbiota were anaerobically or non-aerobically cultured at 37 °C in each plate. Few colonies formed on the 
GAG minimal and GAG + YE0.1 plates. Some colonies were anaerobically grown on the GAG + YE0.5 plate and 
these were picked up with a sterilised tooth pick for streak culture on the GAG + YE0.1 plate to separate single 
colonies. The oxygen conditions of further cultivated colonies were consistent with those of the initial isolation 
cultivation. Finally, two strains H57 and H59 were isolated from the heparin + YE0.5 plate as a heparin-degrading 
microbe through the plate assay for GAG degradation after cultivation on the GAG + YE0.1 + bovine serum 
albumin (BSA) plate for 4 weeks. Strain H57 and H59 cells were identified through a 16S rRNA sequence analysis 
using the standard 27f and 1492r primers (Table S2).
Rapid plate method for the detection of GAG-degrading microbes. GAGs are known to form 
a complex with BSA and the complex is converted to white precipitates in the presence of acetic acid12. After 
inoculation and cultivation of bacterial cells at the centre of medium plates containing BSA and each GAG, 
acetic acid was poured on the plates to form white precipitates in complex with GAGs and BSA. In the case 
of GAG-degrading microbes grown on GAG and BSA-included medium plates, a clear zone (halo) appeared 
around the microbial cells after the addition of acetic acid, because no precipitation by the degraded GAG and 
BSA occurred. Microbial cells from human gut microbiota or standard bacterial cells such as Lactobacillus 
and Bacteroides species were precultured in nutrition-rich medium (Table 1) and the optical density at 600 nm 
(OD600) of the preculture broth was measured. Microbial cells were centrifuged at 9,700 × g for 5 min at room 
temperature, washed with 1 ml of 0.15 M NaCl and resuspended in the saline. The volume (X µl) of the saline to 
the prepare cell suspension was calculated based on the following formula: X = 200 × OD600. The resultant cell 
suspension was subjected to the plate assay for GAG degradation. A portion (10 µl) of the cell suspension was 
spotted at the centre of the BSA-included GAG + YE0.1 plate, and cultured at 30 °C or 37 °C for 7d. After cell 
growth on the plate, 1 ml of 2 M acetic acid was added to form a complex with the remaining GAG and BSA as 
white precipitates.
Adhesion assay. Caco-2 cells were purchased from the Riken Bio Resource Center. The intestinal cells were 
seeded to 12-well plates and grown at 37 °C under a 5% CO2 atmosphere in Dulbecco’s Modified Eagle’s minimal 
essential medium (DMEM) containing 10% fetal bovine serum (Biological Industries) and 1% of a non-essential 
amino acid. For the bacterial adhesion assay, Caco-2 cells were cultured for 21d after seeding and the num-
ber of cells was adjusted to 4.0 × 105 to 6.0 × 105 per each well. After confluent, medium was changed every 
other day. Bacterial cell suspension was prepared in a similar way as mentioned in the section on the rapid plate 
method, with some modifications. In the adhesion assay, 1 ml of the preculture was used to prepare a bacterial 
cell suspension in DMEM in the place of 0.15 M NaCl. The volume (Y µl) of DMEM was calculated based on 
the following formula: Y = 4,000 × OD600. The adhesion of bacterial cells to the monolayer of Caco-2 cells was 
investigated according to previous reports, with some modifications31,32. Each well was washed twice with 1 ml of 
phosphate-buffered saline (PBS) and 0.5 ml of DMEM or 0.5 ml of 30 µg/ml heparin in DMEM was added to each 
well. The bacterial cell suspension (0.5 ml) was further added to each well and incubated at 37 °C under 5% CO2 
atmosphere for 1 h to adhere to Caco-2 cells. Caco-2 cells incubated with bacterial cells were washed three times 
with 1 ml PBS to exclude non-specifically bound bacterial cells. After washing, 1 ml of 0.25% (w/v) triton X-100 
in PBS was added to each well and incubated at 37 °C under 5% CO2 atmosphere for 1 h to lyse Caco-2 cells. The 
bacterial cells showed a resistance to the treatment with triton X-100. The cell lysate containing bacterial cells was 
spread on the MRS plate after serial diluting. Colony-forming units (cfu) were counted as numbers of bacterial 
cells attached to Caco-2 cells after cultivation at 37 °C for 1–2d. The number of bacterial cells attached to Caco-2 
cells were presented as an average ± standard deviation (SD). A significant difference in bound bacterial cells 
between the presence and absence of heparin was determined by a Student’s t-test.
Metagenomics regarding the Bacteroides UGL gene in human gut microbiota. Specific prim-
ers of the Bacteroides UGL gene were designed based on the nucleotide sequences of genes coding for five 
Bacteroides UGLs (Bache_1615 of B. helcogenes P 36–108, BT3348 of B. thetaiotaomicron VPI-5482, BXY_37650 
of Bacteroides xylanisolvens XBIA, BF0331 of Bacteroides fragilis NCTC 9343 and BVU_0115 of B. vulgatus ATCC 
8482) (Table S2). RT-PCR was conducted in the TechnoSuruga Laboratory using total DNA extracted from the 
faeces of the two men in their 20’s and 40’s as a template and primers for 16S rRNA or the Bacteroides UGL gene 
with Illumina HiSeq T. The primers (341f and 534r) for the 16S rRNA gene are shown in Table S2. In the same 
way, RT-PCR was performed using genomic DNA from B. vulgatus as a positive control. The gene fragments 
amplified by RT-PCR were subcloned to a pGEM-T Easy Vector System (Promega) and each of clones from the 
two men was subjected to a determination of nucleotide sequence by the ABI PRISM 3130xl Genetic Analyzer 
System (Applied Biosystems), as previously described33.
Accession codes. The draft genome sequence (108 contigs) of E. faecium strain H57 was deposited in the 
GenBank/EMBL/DDBJ databases under accession numbers BEHC01000001-BEHC01000108.
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